The manifestation of oral mucositis in COVID-19 patients: A
case-series

J 2020

The manifestation of oral mucositis in COVID-19 patients: A case-series

RIAD, Abanoub, Islam KASSEM, Mai BADRAH a Miloslav KLUGAR

Základní údaje

Originální název

The manifestation of oral mucositis in COVID-19 patients: A case-series

Autoři

RIAD, Abanoub (818 Egypt, garant, domácí), Islam KASSEM (818 Egypt), Mai BADRAH (818 Egypt) a Miloslav KLUGAR (203 Česká republika, domácí)

Vydání

Dermatologic Therapy, Hoboken, Wiley, 2020, 1396-0296

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30216 Dermatology and venereal diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.851

Kód RIV

RIV/00216224:14110/20:00116797

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1111/dth.14479

UT WoS

000587315600001

Klíčová slova anglicky

Oral Mucositis; COVID-19

Štítky

14119612, 14119613, rivok

Změněno: 13. 1. 2021 13:39, Mgr. Tereza Miškechová

Anotace

V originále

We have read with great interest the correspondence of Kahraman et al (2020) on the emergence of oral mucosal changes adjacent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; hereby we demonstrate the characteristics of 13 laboratoryconfirmed coronavirus disease (COVID-19) patients with oral mucositis according to the CARE guidelines. The referenced patients sought care at our department from April to August 2020 due to generalized pain and soreness within the oral cavity related mainly to nonkeratinized mucosa without a specific cause (Table 1). All included patients had previously undergone polymerase chain reaction (PCR) testing for SARS-CoV-2, which confirmed their infection with a mean cycle threshold (Ct) value of 18.46 ± 3.8 (12-26). Their mean age was 51.08 ± 8.79 (34-62) years old, and eight of them (62.5%) were females. Regarding their COVID-19 symptoms, two patients (15.4%) had persistent fever, four (30.8%) had ageusia, and two (15.4%) had anosmia. The majority of them (69.2%) had a mild course of SARS-CoV-2 infection and were prescribed paracetamol (PCM); contrarily, four patients experienced a moderate course of infection—two patients (15.4%) were prescribed chloroquine and other two (15.4%) were prescribed dexamethasone.

Citovat

RIAD, Abanoub, Islam KASSEM, Mai BADRAH a Miloslav KLUGAR. The manifestation of oral mucositis in COVID-19 patients: A case-series. Dermatologic Therapy. Hoboken: Wiley, 2020, roč. 33, č. 6, s. 1-3. ISSN 1396-0296. Dostupné z: https://dx.doi.org/10.1111/dth.14479.

@article{1688676,
   author = {Riad, Abanoub and Kassem, Islam and Badrah, Mai and Klugar, Miloslav},
   article_location = {Hoboken},
   article_number = {6},
   doi = {http://dx.doi.org/10.1111/dth.14479},
   keywords = {Oral Mucositis; COVID-19},
   language = {eng},
   issn = {1396-0296},
   journal = {Dermatologic Therapy},
   title = {The manifestation of oral mucositis in COVID-19 patients: A case-series},
   url = {https://onlinelibrary.wiley.com/doi/10.1111/dth.14479},
   volume = {33},
   year = {2020}
}

TY  - JOUR
ID  - 1688676
AU  - Riad, Abanoub - Kassem, Islam - Badrah, Mai - Klugar, Miloslav
PY  - 2020
TI  - The manifestation of oral mucositis in COVID-19 patients: A case-series
JF  - Dermatologic Therapy
VL  - 33
IS  - 6
SP  - 1-3
EP  - 1-3
PB  - Wiley
SN  - 13960296
KW  - Oral Mucositis
KW  - COVID-19
UR  - https://onlinelibrary.wiley.com/doi/10.1111/dth.14479
L2  - https://onlinelibrary.wiley.com/doi/10.1111/dth.14479
N2  - We have read with great interest the correspondence of Kahraman et al (2020) on the emergence of oral mucosal changes adjacent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; hereby we demonstrate the characteristics of 13 laboratoryconfirmed coronavirus disease (COVID-19) patients with oral mucositis according to the CARE guidelines. The referenced patients sought care at our department from April to August 2020 due to generalized pain and soreness within the oral cavity related mainly to nonkeratinized mucosa without a specific cause (Table 1). All included patients had previously undergone polymerase chain reaction (PCR) testing for SARS-CoV-2, which confirmed their infection with a mean cycle threshold (Ct) value of 18.46 ± 3.8 (12-26). Their mean age was 51.08 ± 8.79 (34-62) years old, and eight of them (62.5%) were females. Regarding their COVID-19 symptoms, two patients (15.4%) had persistent fever, four (30.8%) had ageusia, and two (15.4%) had anosmia. The majority of them (69.2%) had a mild course of SARS-CoV-2 infection and were prescribed paracetamol (PCM); contrarily, four patients experienced a moderate course of infection—two patients (15.4%) were prescribed chloroquine and other two (15.4%) were prescribed dexamethasone.
ER  -

RIAD, Abanoub, Islam KASSEM, Mai BADRAH a Miloslav KLUGAR. The manifestation of oral mucositis in COVID-19 patients: A case-series. \textit{Dermatologic Therapy}. Hoboken: Wiley, 2020, roč.~33, č.~6, s.~1-3. ISSN~1396-0296. Dostupné z: https://dx.doi.org/10.1111/dth.14479.

Podrobný výpis o publikaci